Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Svetofor reported for the 3 months of 2024 by RAS

5/30/24 SVET

TMK reduces capex

5/30/24 TRMK

Segezha Group released a trial batch of "green" coal

5/30/24 SGZH

Shareholders of Ryazan Energy Supply Company approved dividends for 2023

5/30/24 RZSB

Aeroflot reported for 3 months of 2024 by IFRS

5/30/24 AFLT

Shareholders of Zaymer approved dividends for 3 months 2024

5/30/24 ZAYM

First Monetka opened in the Republic of Tatarstan

5/30/24 LENT

Board of Directors of Element recommended that dividends be paid for 2023

5/30/24 ELMT

Inter RAO reported for 3 months of 2024 by IFRS

5/30/24 IRAO

Transneft reported for 3 months of 2024 by IFRS

5/30/24 TRNFP